Results 41 to 50 of about 38,667 (276)

Preferential selection of viral escape mutants by CD8+ T cell 'sieving' of SIV reactivation from latency.

open access: yesPLoS Pathogens, 2023
HIV rapidly rebounds after interruption of antiretroviral therapy (ART). HIV-specific CD8+ T cells may act to prevent early events in viral reactivation. However, the presence of viral immune escape mutations may limit the effect of CD8+ T cells on viral
Steffen S Docken   +14 more
doaj   +1 more source

Effector memory differentiation increases detection of replication-competent HIV-l in resting CD4+ T cells from virally suppressed individuals. [PDF]

open access: yes, 2019
Studies have demonstrated that intensive ART alone is not capable of eradicating HIV-1, as the virus rebounds within a few weeks upon treatment interruption.
Bale, Michael J   +13 more
core   +1 more source

Viral suppression and viral rebound among young adults living with HIV in Canada

open access: yesMedicine, 2018
Describe the prevalence and covariates of viral suppression and subsequent rebound among younger (≤29 years old) compared with older adults.A retrospective clinical cohort study; eligibility criteria: documented HIV infection; resident of Canada; 18 years and over; first antiretroviral regimen comprised of at least 3 individual agents on or after ...
Palmer, Alexis   +13 more
openaire   +2 more sources

Multiple imputation approach for interval-censored time to HIV RNA viral rebound within a mixed effects Cox model [PDF]

open access: yes, 2018
This is the peer reviewed version of the following article: “Alarcón-Soto, Y, Langohr K., Fehér, C., García, F., and Gómez, G. (2018) Multiple imputation approach for interval-censored time to HIV RNA viral rebound within a mixed effects Cox Model ...
Alarcón Soto, Yovaninna   +4 more
core   +2 more sources

Latent HIV dynamics and implications for sustained viral suppression in the absence of antiretroviral therapy

open access: yesJournal of Virus Eradication, 2018
Objectives: The interaction between HIV and the immune system gives rise to a complex dynamical system. We therefore investigate whether delayed viral rebound after antiretroviral therapy (ART) interruption (ATI) may be due to an individual's viral ...
John M. Murray
doaj   +1 more source

Early and Highly Suppressive ART are Main Factors Associated with Low Viral Reservoir in European Perinatally HIV Infected Children [PDF]

open access: yes, 2018
BACKGROUND: Future strategies aiming to achieve HIV-1 remission are likely to target individuals with small reservoir size. SETTING: We retrospectively investigated factors associated with HIV-1 DNA levels in European, perinatally HIV-infected ...
Babiker, Abdel   +22 more
core   +2 more sources

Predictors of SIV recrudescence following antiretroviral treatment interruption

open access: yeseLife, 2019
There is currently a need for proxy measures of the HIV rebound competent reservoir (RCR) that can predict viral rebound after combined antiretroviral treatment (cART) interruption.
Mykola Pinkevych   +7 more
doaj   +1 more source

Human immunodeficiency virus rebound after suppression to < 400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression [PDF]

open access: yes, 2002
This study evaluated 1433 human immunodeficiency virus (HIV)-infected patients starting highly active antiretroviral therapy (HAART), 409 (28%) of whom had prior nucleoside experience and achieved an HIV load of
Bickel, M   +11 more
core   +1 more source

Factors associated with post-treatment control of viral load in HIV-infected patients: a systematic review and meta-analysis

open access: yesInternational Journal of Infectious Diseases, 2023
Objectives: This study aimed to investigate the factors associated with maintenance of viral suppression after antiretroviral therapy (ART) discontinuation.
Chi Zhou   +7 more
doaj   +1 more source

Evolution of experimental design and research techniques in HIV-1 reservoir studies : a systematic review

open access: yes, 2020
Although HIV-1 has evolved from a deadly to a chronic disease over the past 20 years, an HIV-1 cure is still lacking due to the presence of persisting cellular viral reservoirs which are spread throughout the body in different anatomical compartments ...
De Scheerder, Marie-Angélique   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy